INVA earnings: real EPS beat/miss history, analyst consensus Buy, P/E 3.05. Updated 2026-07-23.
Innoviva (INVA) Research Hub
Innoviva (INVA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 20.66 USD (-2.22%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 3.05, market cap 1.58B. This hub links to the full technical, earnings and options research available for INVA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 20.66 USD (-2.22%) |
| 52-week range | 20.2 USD – 24.17 USD |
| Trend regime | Range |
| 14-day RSI | 52.6 (Neutral) |
| Trailing P/E | 3.05 |
| Market cap | 1.58B |
| Dividend yield | 0.00% |
Available research for INVA
Covered Call on INVA: how it works, illustrative setup around the real 20.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INVA: how it works, illustrative setup around the real 20.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INVA: how it works, illustrative setup around the real 20.66 USD price, max profit/loss, breakeven and when to use it. Educational.
INVA technical analysis: range, last 20.66 USD, RSI 52.6, 52w range 20.2 USD–24.17 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is INVA in?
Innoviva (INVA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INVA in an uptrend or downtrend?
As of 2026-09-11, INVA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INVA's trailing P/E ratio?
INVA's trailing P/E is 3.05, with a market cap of 1.58B. See the earnings research page for full valuation detail.